Capecitabine‐containing regimens vs chemotherapy regimens without capecitabine
Disease-free survival · neoadjuvant treatment of ER‐positive vs ER‐negative breast cancer
Capecitabine‐containing regimens showed no clear difference in disease‐free survivalmedian compared with non‐capecitabine‐containing regimens (high certainty).
1 finding from 1 review
- Capecitabine for hormone receptor‐positive versus hormone receptor‐negative breast cancer 2021 · Cochrane Headline outcomes onlyHR 1.02 [0.86, 1.21]4 studies · 2499 participantsHigh